The role of cytomegalovirus colitis on short- and long-term outcomes for patients with ulcerative colitis

References

• Razonable RR, Humar A. Cytomegalovirus in solid organ transplantation. Am J Transplant. 2013;13 (Suppl 4):93–106.
   PubMedGoogle Scholar
• Rahier JF, Magro F, Abreu C, et al. Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014;8(6):443–468.
   PubMed Web of Science ®Google Scholar
• Lv YL, Han FF, Jia YJ, et al. Is cytomegalovirus infection related to inflammatory bowel disease, especially steroid-resistant inflammatory bowel disease? A Meta-analysis. Infect Drug Resist. 2017;10:511–519.
   PubMed Web of Science ®Google Scholar
• Jentzer A, Veyrard P, Roblin X, et al. Cytomegalovirus and inflammatory bowel diseases (IBD) with a special focus on the link with ulcerative colitis (UC). Microorganisms. 2020;8(7):1078.
   Web of Science ®Google Scholar
• Wu XW, Wu L, Ji HZ, et al. Relationship between cytomegalovirus infection and steroid resistance in inflammatory bowel disease: a meta-analysis. Dig Dis Sci. 2015;60(11):3203–3208.
   PubMed Web of Science ®Google Scholar
• Kim YS, Kim YH, Kim JS, et al. Long-term outcomes of cytomegalovirus reactivation in patients with moderate to severe ulcerative colitis: a multicenter study. Gut Liver. 2014;8(6):643–647.
   PubMed Web of Science ®Google Scholar
• Oh SJ, Lee CK, Kim YW, et al. True cytomegalovirus colitis is a poor prognostic indicator in patients with ulcerative colitis flares: the 10-year experience of an academic referral inflammatory bowel disease center. Scand J Gastroenterol. 2019;54:976–983.
   PubMed Web of Science ®Google Scholar
• Zagórowicz E, Bugajski M, Wieszczy P, et al. Cytomegalovirus infection in ulcerative colitis is related to severe inflammation and a high count of cytomegalovirus-positive cells in biopsy is a risk factor for colectomy. J Crohns Colitis. 2016;10(10):1205–1211.
   PubMed Web of Science ®Google Scholar
• Jain S, Namdeo D, Sahu P, et al. High mucosal cytomegalovirus DNA helps predict adverse short-term outcome in acute severe ulcerative colitis. Intest Res. 2021;19(4):438–447.
   PubMed Web of Science ®Google Scholar
• Schenk W, Klugmann T, Borkenhagen A, et al. The detection of the cytomegalovirus DNA in the colonic mucosa of patients with ulcerative colitis is associated with increased long-term risk of proctocolectomy: results from an outpatient IBD clinic. International Journal of Colorectal Disease. 2019;34:393–400.
   PubMed Web of Science ®Google Scholar
• Magro F, Gionchetti P, Eliakim R, et al. Third european evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11(6):649–670.
   PubMed Web of Science ®Google Scholar
• Yang H, Zhou W, Lv H, et al. The association between CMV viremia or endoscopic features and histopathological characteristics of CMV colitis in patients with underlying ulcerative colitis. Inflamm Bowel Dis. 2017;23:814–821.
   PubMed Web of Science ®Google Scholar
• Truelove S, Witts L. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2(4947):1041–1048.
   PubMed Web of Science ®Google Scholar
• Colombel JF, Loftus EV, Jr., Tremaine WJ, et al. Early postoperative complications are not increased in patients with crohn's disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterology. 2004;99(5):878–883.
   PubMed Web of Science ®Google Scholar
• Yang H, Wu K, Zhang H, et al. IgA, albumin, and eosinopenia as early indicators of cytomegalovirus infection in patients with acute ulcerative colitis. BMC Gastroenterol. 2020;20:294.
   PubMed Web of Science ®Google Scholar
• Poston RN, Morgan RS. Interactions between soluble IgG, complement and cells in lymphocyte and monocyte ADCC. Immunology. 1983;50(3):461–469.
   PubMed Web of Science ®Google Scholar
• Yomota M, Amano I, Horita N, et al. Serum immunoglobulin G is a marker for the risk of opportunistic infection in steroid-dependent severe asthmatic patients. Intern Med. 2012;51(19):2715–2719.
   PubMed Web of Science ®Google Scholar
• Horton N, Wu X, Philpott J, et al. Impact of low immunoglobulin G levels on disease outcomes in patients with inflammatory bowel diseases. Dig Dis Sci. 2016;61(11):3270–3277.
   PubMed Web of Science ®Google Scholar
• Posey WC, Nelson HS, Branch B, et al. The effects of acute corticosteroid therapy for asthma on serum immunoglobulin levels. J Allergy Clin Immunol. 1978;62(6):340–348.
   PubMed Web of Science ®Google Scholar
• Rai T, Wu X, Shen B. Frequency and risk factors of low immunoglobulin levels in patients with inflammatory bowel disease. Gastroenterol Rep (Oxf). 2015;3(2):115–121.
   PubMed Web of Science ®Google Scholar
• Di Sabatino A, Carsetti R, Rosado MM, et al. Immunoglobulin M memory B cell decrease in inflammatory bowel disease. Eur Rev Med Pharmacol Sci . 2004;8:199–203.
   PubMedGoogle Scholar
• Zhang WX, Ma CY, Zhang JG, et al. Effects of cytomegalovirus infection on the prognosis of inflammatory bowel disease patients. Exp Ther Med. 2016;12(5):3287–3293.
   PubMed Web of Science ®Google Scholar
• Lee HS, Park SH, Kim SH, et al. Risk factors and clinical outcomes associated with cytomegalovirus colitis in patients with acute severe ulcerative colitis. Inflamm Bowel Dis. 2016;22(4):912–918.
   PubMed Web of Science ®Google Scholar
• Shukla T, Singh S, Tandon P, et al. Corticosteroids and thiopurines, but not tumor necrosis factor antagonists, are associated with cytomegalovirus reactivation in inflammatory bowel disease: a systematic review and Meta-Analysis. J Clin Gastroenterol. 2017;51(5):394–401.
   PubMed Web of Science ®Google Scholar
• Olnes MJ, Kotliarov Y, Biancotto A, et al. Effects of systemically administered hydrocortisone on the human immunome. Sci Rep. 2016;6:23002.
   PubMed Web of Science ®Google Scholar
• Inokuchi T, Kato J, Hiraoka S, et al. Long-term follow-up of ulcerative colitis patients treated on the basis of their cytomegalovirus antigen status. World J Gastroenterol. 2014;20(2):509–517.
   PubMed Web of Science ®Google Scholar
• Khan N, Patel D, Shah Y, et al. Albumin as a prognostic marker for ulcerative colitis. World J Gastroenterol. 2017;23(45):8008–8016.
   PubMed Web of Science ®Google Scholar
• Thapa SD, Hadid H, Usman M, et al. Predictors of thiopurine treatment failure in biologic-naive ulcerative colitis patients. Dig Dis Sci. 2016;61(1):230–237.
   PubMed Web of Science ®Google Scholar
• Syal G, Robbins L, Kashani A, et al. Hypoalbuminemia and bandemia predict failure of infliximab rescue therapy in acute severe ulcerative colitis. Dig Dis Sci. 2021;66(1):199–205.
   PubMed Web of Science ®Google Scholar
• Johnson J, Affolter K, Boynton K, et al. CMV disease in IBD: comparison of diagnostic tests and correlation with disease outcome. Inflamm Bowel Dis. 2018;24(7):1539–1546.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Chen B, Li Y, et al. Risk factors and long-term outcome of disease extent progression in Asian patients with ulcerative colitis: a retrospective cohort study. BMC Gastroenterol. 2019;19:7.
   PubMed Web of Science ®Google Scholar
• Bertani L, Bodini G, Mumolo MG, et al. Corticosteroid treatment at diagnosis: an analysis of relapses, disease extension, and colectomy rate in ulcerative colitis. Dig Dis Sci. 2020;65:2397–2402.
   PubMed Web of Science ®Google Scholar
• Domenech E, Vega R, Ojanguren I, et al. Cytomegalovirus infection in ulcerative colitis: a prospective, comparative study on prevalence and diagnostic strategy. Inflamm Bowel Dis. 2008;14(10):1373–1379.
   PubMed Web of Science ®Google Scholar